Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease. / Frikke-Schmidt, R.; Nordestgaard, Børge; Grande, Peer; Tybjærg-Hansen, Anne; Schnohr, Peter.

In: Journal of the American College of Cardiology, Vol. 52, No. 5, 2008, p. 369-377.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Frikke-Schmidt, R, Nordestgaard, B, Grande, P, Tybjærg-Hansen, A & Schnohr, P 2008, 'Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease', Journal of the American College of Cardiology, vol. 52, no. 5, pp. 369-377. https://doi.org/10.1016/j.jacc.2008.03.059

APA

Frikke-Schmidt, R., Nordestgaard, B., Grande, P., Tybjærg-Hansen, A., & Schnohr, P. (2008). Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease. Journal of the American College of Cardiology, 52(5), 369-377. https://doi.org/10.1016/j.jacc.2008.03.059

Vancouver

Frikke-Schmidt R, Nordestgaard B, Grande P, Tybjærg-Hansen A, Schnohr P. Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease. Journal of the American College of Cardiology. 2008;52(5):369-377. https://doi.org/10.1016/j.jacc.2008.03.059

Author

Frikke-Schmidt, R. ; Nordestgaard, Børge ; Grande, Peer ; Tybjærg-Hansen, Anne ; Schnohr, Peter. / Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease. In: Journal of the American College of Cardiology. 2008 ; Vol. 52, No. 5. pp. 369-377.

Bibtex

@article{e7222c80f74a11ddbf70000ea68e967b,
title = "Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease",
abstract = "Objectives This study was designed to test the hypotheses that single nucleotide polymorphisms ( SNPs), in zinc finger protein 202 ( ZNF202), predict severe atherosclerosis and ischemic heart disease ( IHD). Background ZNF202 is a transcriptional repressor controlling promoter elements in genes involved in vascular maintenance and lipid metabolism. Methods We first determined genotype association for 9 ZNF202 SNPs with severe atherosclerosis ( ankle brachial index >0.7 vs. <= 0.7) in a cross-sectional study of 5,355 individuals from the Danish general population. We then determined genotype association with IHD in 10,431 individuals from the Danish general population, the CCHS ( Copenhagen City Heart Study), including 1,511 incident IHD events during 28 years of follow-up. Results were verified in 2 independent case-control studies including, respectively, 942 and 1,549 cases with IHD and 8,998 controls. Finally, we determined whether g. -660A>G altered transcriptional activity of the ZNF202 promoter in vitro. Results Cross-sectionally, ZNF202 g. -660 GG versus AA homozygosity predicted an odds ratio for severe atherosclerosis of 2.01 ( 95% confidence interval [CI]: 1.34 to 3.01). Prospectively, GG versus AA homozygosity predicted a hazard ratio for IHD of 1.21 ( 95% CI: 1.02 to 1.43). In the 2 case-control studies, the equivalent odds ratios for IHD were 1.29 ( 95% CI: 1.02 to 1.62) and 1.60 ( 95% CI: 1.34 to 1.92), confirming the results from the prospective study. Only 2 other SNPs, which were highly correlated with g. -660A>G, also predicted risk of severe atherosclerosis and IHD. Finally, ZNF202 g. -660G versus g. -660A was associated with a 60% reduction in transcriptional activity in vitro, whereas none of the 2 correlated SNPs were predicted to be functional. Conclusions Homozygosity for a common functional promoter variant in ZNF202 predicts severe atherosclerosis and an increased risk of IHD Udgivelsesdato: 2008/7/29",
author = "R. Frikke-Schmidt and B{\o}rge Nordestgaard and Peer Grande and Anne Tybj{\ae}rg-Hansen and Peter Schnohr",
note = "Times Cited: 1ArticleEnglishTybjaerg-Hansen, AUniv Copenhagen Hosp, Rigshosp, Dept Clin Biochem KB3011, Mol Genet Sect, Blegdamsvej 9, DK-2100 Copenhagen, DenmarkCited References Count: 29329CPELSEVIER SCIENCE INC360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USANEW YORK",
year = "2008",
doi = "10.1016/j.jacc.2008.03.059",
language = "English",
volume = "52",
pages = "369--377",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier",
number = "5",

}

RIS

TY - JOUR

T1 - Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease

AU - Frikke-Schmidt, R.

AU - Nordestgaard, Børge

AU - Grande, Peer

AU - Tybjærg-Hansen, Anne

AU - Schnohr, Peter

N1 - Times Cited: 1ArticleEnglishTybjaerg-Hansen, AUniv Copenhagen Hosp, Rigshosp, Dept Clin Biochem KB3011, Mol Genet Sect, Blegdamsvej 9, DK-2100 Copenhagen, DenmarkCited References Count: 29329CPELSEVIER SCIENCE INC360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USANEW YORK

PY - 2008

Y1 - 2008

N2 - Objectives This study was designed to test the hypotheses that single nucleotide polymorphisms ( SNPs), in zinc finger protein 202 ( ZNF202), predict severe atherosclerosis and ischemic heart disease ( IHD). Background ZNF202 is a transcriptional repressor controlling promoter elements in genes involved in vascular maintenance and lipid metabolism. Methods We first determined genotype association for 9 ZNF202 SNPs with severe atherosclerosis ( ankle brachial index >0.7 vs. <= 0.7) in a cross-sectional study of 5,355 individuals from the Danish general population. We then determined genotype association with IHD in 10,431 individuals from the Danish general population, the CCHS ( Copenhagen City Heart Study), including 1,511 incident IHD events during 28 years of follow-up. Results were verified in 2 independent case-control studies including, respectively, 942 and 1,549 cases with IHD and 8,998 controls. Finally, we determined whether g. -660A>G altered transcriptional activity of the ZNF202 promoter in vitro. Results Cross-sectionally, ZNF202 g. -660 GG versus AA homozygosity predicted an odds ratio for severe atherosclerosis of 2.01 ( 95% confidence interval [CI]: 1.34 to 3.01). Prospectively, GG versus AA homozygosity predicted a hazard ratio for IHD of 1.21 ( 95% CI: 1.02 to 1.43). In the 2 case-control studies, the equivalent odds ratios for IHD were 1.29 ( 95% CI: 1.02 to 1.62) and 1.60 ( 95% CI: 1.34 to 1.92), confirming the results from the prospective study. Only 2 other SNPs, which were highly correlated with g. -660A>G, also predicted risk of severe atherosclerosis and IHD. Finally, ZNF202 g. -660G versus g. -660A was associated with a 60% reduction in transcriptional activity in vitro, whereas none of the 2 correlated SNPs were predicted to be functional. Conclusions Homozygosity for a common functional promoter variant in ZNF202 predicts severe atherosclerosis and an increased risk of IHD Udgivelsesdato: 2008/7/29

AB - Objectives This study was designed to test the hypotheses that single nucleotide polymorphisms ( SNPs), in zinc finger protein 202 ( ZNF202), predict severe atherosclerosis and ischemic heart disease ( IHD). Background ZNF202 is a transcriptional repressor controlling promoter elements in genes involved in vascular maintenance and lipid metabolism. Methods We first determined genotype association for 9 ZNF202 SNPs with severe atherosclerosis ( ankle brachial index >0.7 vs. <= 0.7) in a cross-sectional study of 5,355 individuals from the Danish general population. We then determined genotype association with IHD in 10,431 individuals from the Danish general population, the CCHS ( Copenhagen City Heart Study), including 1,511 incident IHD events during 28 years of follow-up. Results were verified in 2 independent case-control studies including, respectively, 942 and 1,549 cases with IHD and 8,998 controls. Finally, we determined whether g. -660A>G altered transcriptional activity of the ZNF202 promoter in vitro. Results Cross-sectionally, ZNF202 g. -660 GG versus AA homozygosity predicted an odds ratio for severe atherosclerosis of 2.01 ( 95% confidence interval [CI]: 1.34 to 3.01). Prospectively, GG versus AA homozygosity predicted a hazard ratio for IHD of 1.21 ( 95% CI: 1.02 to 1.43). In the 2 case-control studies, the equivalent odds ratios for IHD were 1.29 ( 95% CI: 1.02 to 1.62) and 1.60 ( 95% CI: 1.34 to 1.92), confirming the results from the prospective study. Only 2 other SNPs, which were highly correlated with g. -660A>G, also predicted risk of severe atherosclerosis and IHD. Finally, ZNF202 g. -660G versus g. -660A was associated with a 60% reduction in transcriptional activity in vitro, whereas none of the 2 correlated SNPs were predicted to be functional. Conclusions Homozygosity for a common functional promoter variant in ZNF202 predicts severe atherosclerosis and an increased risk of IHD Udgivelsesdato: 2008/7/29

U2 - 10.1016/j.jacc.2008.03.059

DO - 10.1016/j.jacc.2008.03.059

M3 - Journal article

C2 - 18652945

VL - 52

SP - 369

EP - 377

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 5

ER -

ID: 10240964